HER2 and Chromosome 17 Effect on Patient Outcome in the N9831 Adjuvant Trastuzumab Trial
- Citation:
- J Clin Oncol vol 28 (28) 4307-4315
- Year:
- 2010
- Type:
- Manuscript
- Funding:
- NCTN
- Endpoint:
- Secondary
- Analysis:
- Primary
- Data Sharing:
- No-Data-Sharing
- Status:
- Presented/Published
- Citation Status:
- pmc-release
- Note:
- Methodological:
- No
- Biospecimen:
- No
- SDC:
- No
- Book Volume:
- Parents:
- 682
- Children:
- None
- Pharmas:
- Grants:
- U24 CA114740, CA114740, R01 CA129949, CA129949, CA25224, U10 CA025224
- Corr. Author:
- Authors:
- Edith A. Perez Monica M. Reinholz David W. Hillman Kathleen S. Tenner Matthew J. Schroeder Nancy E. Davidson Silvana Martino George W. Sledge Lyndsay N. Harris Julie R. Gralow Amylou C. Dueck Rhett P. Ketterling James N. Ingle Wilma L. Lingle Peter A. Kaufman Daniel W. Visscher Robert B. Jenkins
- Networks:
- Study
- NCCTG-N9831
- Multiple Studies, or Legacy Studies in Alliance Study:
- Phases:
- 3
- Keywords:
- Bc5, Original Reports, Breast Cancer